An exploratory analysis of the regionalization policy for the recruitment of health workers in Burkina Faso

BACKGROUND: Health personnel retention in remote areas is a key health systems issue wordwide. To deal with this issue, since 2002 the government of Burkina Faso has implemented a staff retention policy, the regionalized health personnel recruitment policy, aimed at front-line workers such as nurses, midwives, and birth attendants. This study aimed to describe the policy’s development, formulation, and implementation process for the regionalization of health worker recruitment in Burkina Faso. METHODS: We conducted a qualitative study. The unit of analysis is a single case study with several levels of analysis. This study was conducted in three remote areas in Burkina Faso for the implementation portion, and at the central level for the development portion. Indepth interviews were conducted with Ministry of Health officials in charge of human resources, regional directors, regional human resource managers, district chief medical officers, and health workers at primary health centres. In total, 46 indepth interviews were conducted (February 3 - March 16, 2011). RESULTS: Development The idea for this policy emerged after finding a highly uneven distribution of health personnel across urban and rural areas, the availability of a large number of health officers in the labour market, and the opportunity given to the Ministry of Health by the government to recruit personnel through a specific budget allocation. Formulation The formulation consisted of a call for job applications from the Ministry of Health, which indicates the number of available posts by region. The respondents interviewed unanimously acknowledged the lack of documents governing the status of this new personnel category. Implementation During the initial years of implementation (2002-2003), this policy was limited to recruiting health workers for the regions with no possibility of transfer. The possibility of job-for-job exchange was then approved for a certain time, then cancelled. Starting in 2005, a departure condition was added. Now, regionalized health workers can leave the regions after undergoing a competitive selection process. CONCLUSION: The policy was characterized by the absence of written directives and by targeting only one category of personnel. Moreover, there was no associated incentive—financial or otherwise—which poses the question of long-term viability

Profil épidémiologique de la rougeole au Mali de 2009 à 2018: Epidemiological profile of measles in Mali from 2009 to 2018

Introduction: La rougeole, maladie virale hautement contagieuse causée par un Morbillivirus, reste un important problèeme de santé publique dans de nombreux pays malgré l'existence d'un vaccin efficace. La surveillance de la rougeole est l'un des aspects clés de la lutte contre cette maladie. La présente étude avait pour objectif de décrire la mortalité et la morbidité de la rougeole au Mali entre 2009 et 2018. Méthodes: Il s'agissait d'étude transversale descriptive. Les données de surveillance de la rougeole au Mali de 2009 à 2018 ont été analysées en personne, lieu et temps. Résultats: De 2009 à 2018, le nombre de cas confirmés de rougeole était de 6461 dont 29 décès soit une létalité de 0,45%. La confirmation des cas avait été faite par le laboratoire pour 2551 cas (39,48%), par lien épidémiologique pour 3738 cas (57,85%) et cliniquement pour 172 cas (2,66%). Les enfants de moins de 5 ans représentaient 50,97% des cas et 75,86% des décès. La majorité des cas (95,71 %) n'avaient jamais été vaccinés contre la rougeole. Les incidences les plus élevées avaient été observées en 2009 (22,65 pour 100 000 hbts) et 2010 (11,81 pour 100 000 hbts). Tombouctou, Gao et Mopti avaient enregistrés les plus grands nombres de cas en 2009 et Bamako, Koulikoro et Mopti en 2010. Conclusion: La majorité des cas et des décès étaient les enfants non vaccinés de moins de cinq ans. Un renforcement du programme élargi de vaccination de routine, une riposte aux épidéemies et des stratéegies de vaccination couvrant tout le pays sont nécessaires. Introduction: Measles, a highly contagious viral disease caused by a Morbillivirus, remains an important public health problem in many countries despite the availability of an effective vaccine. Measles surveillance is one of the key aspects of measles control. The objective of this study was to describe measles mortality and morbidity in Mali between 2009 and 2018. Methods: This was a descriptive cross-sectional study. Measles surveillance data in Mali from 2009 to 2018 were analysed by person, place and time. Results: From 2009 to 2018, the number of confirmed measles cases was 6461 including 29 deaths, i.e. a case-fatality rate of 0.45%. Cases were confirmed by the laboratory for 2551 cases (39.48%), by epidemiological link for 3738 cases (57.85%) and clinically for 172 cases (2.66%). Children under 5 years of age represented 50.97% of cases and 75.86% of deaths. The majority of cases (95.71%) had never been vaccinated against measles. The highest incidences were observed in 2009 (22.65 per 100,000 inhabitants) and 2010 (11.81 per 100,000 inhabitants). Timbuktu, Gao and Mopti had the highest number of cases in 2009 and Bamako, Koulikoro and Mopti in 2010. Conclusion: The majority of cases and deaths were among unvaccinated children under five years of age. Strengthening of the routine expanded programme of immunisation, response to epidemics and nationwide immunisation strategies are needed

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Facteurs Associés à l’Anémie Sévère de la Grossesse en Milieu Hospitalier dans la Région des Cascades au Burkina Faso.

info:eu-repo/semantics/publishe

Synthesis, crystal structure and electrochemical properties of a new methylammonium sodium decavanate salt Na3(CH3NH3)3[V10O28].(CH3NH2).14H2O

International audienceA new hybrid decavanadate Na-3(CH3NH3)(3) [V10O28](center dot)(CH3NH2)(center dot)14H(2)O was obtained by a simple synthesis in solution and the crystal structure was determined by single-crystal X-ray diffraction. The compound consists of decavanadate anions [V10O28](6-) isolated between sodium and methylammonium cations. The UV-Visible absorption, IR spectroscopy as well as electrochemical properties were characterized. The compound crystalizes in a triclinic system (space group P-1) with the unit cell parameters: a = 10.1584(11) angstrom, b = 10.8123(5) angstrom, c = 11.1582(7) angstrom, alpha = 107.723(4)degrees, beta = 106.811(5)degrees, gamma = 94.238(7)degrees. UV-Visible absorption spectroscopy shows a strong absorption band at 300 nm. The main IR absorption bands appear at: 954 cm(-1), 800 cm(-1), 732 cm(-1) and 580 cm(-1).The electrochemical measurement of this compound shows two reversible one-electron redox process -105 mV (I-I') and 335mV(II-II'), which was attributed to two consecutive one-electron V-V -> V-IV reductions